
The objective of this study was to characterize the maximum tolerated dose zzso zzso zzso zzso zzso and zzso effects of zzso a novel zzso zzso in zzso solid tumor zzso zzso was given for 5 consecutive days for 2 weeks, repeated every 3 weeks at zzso to zzso zzso zzso events were monitored following zzso zzso of zzso and total forms were determined using validated zzso liquid zzso zzso and zzso zzso zzso was evaluated applying World Health Organization zzso zzso The 1st course was used to determine zzso and zzso Twenty-five patients received 73 courses of zzso zzso and zzso were zzso zzso was 120 zzso zzso increased approximately zzso with zzso The zzso for zzso and total forms was zzso and 29 hours, zzso zzso correlated significantly with zzso zzso and grade 4 zzso Two complete responses zzso and 2 partial responses zzso were zzso In addition, 4 stable diseases were zzso The recommended phase II dose is 80 zzso 

